Please use this identifier to cite or link to this item: https://doi.org/10.1080/09273948.2022.2026414
DC FieldValue
dc.titleOutcome Measures for Disease Monitoring in Intraocular Inflammatory and Infectious Diseases (OCTOMERIA): Understanding the choroid in uveitis with optical coherence tomography (OCT)
dc.contributor.authorRupesh Agrawa
dc.contributor.authorRei Chern Weng
dc.contributor.authorAlex Fonollosa
dc.contributor.authorLena Giralt
dc.contributor.authorJoseba Artaraz
dc.contributor.authorPeizeng Yang
dc.contributor.authorFanfan Huang
dc.contributor.authorBingyao Tan
dc.contributor.authorLeopold Schmetterer
dc.contributor.authorAlok Sen
dc.contributor.authorVishali Gupta
dc.contributor.authorWei Xin
dc.date.accessioned2023-03-10T01:53:29Z
dc.date.available2023-03-10T01:53:29Z
dc.date.issued2022-02-24
dc.identifier.citationRupesh Agrawa, Rei Chern Weng, Alex Fonollosa, Lena Giralt, Joseba Artaraz, Peizeng Yang, Fanfan Huang, Bingyao Tan, Leopold Schmetterer, Alok Sen, Vishali Gupta, Wei Xin (2022-02-24). Outcome Measures for Disease Monitoring in Intraocular Inflammatory and Infectious Diseases (OCTOMERIA): Understanding the choroid in uveitis with optical coherence tomography (OCT). Ocular Immunology and Inflammation 31 (2) : 374-392. ScholarBank@NUS Repository. https://doi.org/10.1080/09273948.2022.2026414
dc.identifier.issn0927-3948
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/238033
dc.publisherTaylor & Francis
dc.sourceTaylor & Francis
dc.typeReview
dc.contributor.departmentDUKE-NUS MEDICAL SCHOOL
dc.description.doi10.1080/09273948.2022.2026414
dc.description.sourcetitleOcular Immunology and Inflammation
dc.description.volume31
dc.description.issue2
dc.description.page374-392
Appears in Collections:Staff Publications
Elements
Students Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10.108009273948.2022.2026414.zip7.48 MBZIP

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.